About this policy
CMS evidence review | evidence_type=MEDCAC Meeting | record_type=medcac_meeting | document_id=83 | meeting_date=2025-03-26
Coverage indications
On March 26, 2025, the Centers for Medicare & Medicaid Services (CMS) convened a subcommittee of a Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel. The MEDCAC panel will consider which clinical endpoints in studies of devices to manage tremor in Parkinson’s disease and essential tremor should be of interest to CMS. The purpose of the March 26 subcommittee meeting was to discuss in depth a literature-based Clinical Endpoints Review (CER) on this topic, review comments on the CER from three external neurology/neurosurgery physicians and assist CMS in formulating voting questions for the full panel meeting that will be held on June 25, 2025. The full MEDCAC panel will review the CER and the expert commentary. By voting on specific questions and through discussion, MEDCAC panel members will advise CMS about the ideal clinical endpoints to measure in research studies on this topic, appropriate measurement instruments, definitions of minimal clinically important differences and adequate follow-up duration.
Documentation requirements
Actions Taken: April 24, 2025 Posted materials from meeting. 06/25/2025 - Devices to Manage Tremor in Parkinson’s Disease and Essential Tremor Agenda: Federal Register Notice Issue: On March 26, 2025, the Centers for Medicare & Medicaid Services (CMS) convened a subcommittee of a Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) panel. The MEDCAC panel will consider which clinical endpoints in studies of devices to manage tremor in Parkinson’s disease and essential tremor should be of interest to CMS. The purpose of the March 26 subcommittee meeting was to discuss in depth a literature-based Clinical Endpoints Review (CER) on this topic, review comments on the CER from three external neurology/neurosurgery physicians and assist CMS in formulating voting questions for the full panel meeting that will be held on June 25, 2025. The full MEDCAC panel will review the CER and the expert commentary. By voting on specific questions and through discussion, MEDCAC panel members will advise CMS about the ideal clinical endpoints to measure in research studies on this topic, appropriate measurement instruments, definitions of minimal clinically important differences and adequate follow-up duration. Minutes: Download meeting minutes . Other Material: Transcript 1 Appendix A. Evidentiary search strategy Clinical Endpoints Review Document Reviewer responses to the Clinical Endpoints Review Document Clinical Endpoints Review Summary CER Presentation Panel Roster: Committee Chair: Joseph Ross, MD, MHS Professor of Medicine and Public Health Section of General Internal Medicine Department of Medicine Yale University School of Medicine Committee Vice Chair: Sanket Dhruva, MD, MHS, FACC Associate Professor of Medicine (Cardiology), UCSF School of Medicine Affiliate Faculty, Philip R. Lee Institute for Health Policy Studies MEDCAC Members: Timothy J. Barreiro, DO, MPH, FCCP, MACOI, FACP Section Chair, Pulmonary & Critical Care Professor of Internal Medicine NIH Health Minority & Harvard Macy Scholar Ohio University Heritage College of Osteopathic Medicine Northeast Ohio Medical University Director, Pulmonary Health & Research Center Pooja Khatri, MD, MSc Chair of Neurology, Yale School of Medicine Neurologist-In-Chief, Yale New Haven Health System Patient Advocate Amy Goldsmith, MA, CCC-SLP, RAC-CT, CMAC Chief Operating Officer Reimbursement Reimagined Industry Representatives Laura Mauri, MD, MSc Senior Vice President Chief Scientific and Medical Officer Medtronic
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.